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New Preparation Method Using Microwave, Kinetics, In
Vitro Dissolution-Diffusion, and Anti-Inflammatory Study of
Diclofenac- Proline Co–Crystal
Ilma Nugrahani,*[a] Dwi Utami,[b] Livia Ayuningtyas,[a] Afrillia Nuryanti Garmana,[a] and
Rozana Oktaviary*[a]
In this study, we developed a novel and simple method to
prepare an established diclofenac-proline co-crystal (DPC) using
microwave. In addition, we also evaluate the pharmaceutical
properties of the co-crystal, including dissolution, diffusion, and
anti-inflammatory profile. The kinetics of co-crystal formation
was investigated using Fourier-transform infrared spectroscopy.
The co-crystal yield was confirmed physically by differential
scanning calorimetry and powder x-ray diffraction, while the
chemical stability of the drug during and after microwaving
was confirmed using thin layer chromatography, ultraviolet
spectrophotometry and high-performance liquid chromatogra-
phy. Experiment results demonstrated that microwave can
generate the stable and uniform quality of diclofenac-proline
co-crystal efficiently. Furthermore, the process was investigated
to follow a second order kinetic, which is different than the
neat-grinding process previously reported. Moreover, our
findings revealed that co-crystals with L-proline can signifi-
cantly improve the dissolution, diffusion, and anti-inflammation
activity of diclofenac acid.
Introduction
Poor homogeneity and low purity are two primary obstacles
faced in the development of co-crystal production. Usually,
starting materials are still found in the resulting co-crystal
product, corresponding to low yield.[1–3] Some methods have
been reported to address these issues, including neat grinding,
liquid-assisted grinding, hot extrusion, and slow evaporation,
all of which have specific advantages and disadvantages.[4–7]
Mechanochemical processes such as grinding, with or without
solvents, is laborious in terms of maintaining the continuity
due to particle size, surface property changes, and the electro-
static effect during the process.[8] Other methods such as slow
evaporation have disadvantages, including difficulty maintain-
ing the co-solubility of the parent materials in solution due to
their inherent different polarities and dielectric constants,[9–11]
while the hot extrusion/melting method has a high risk of
chemical instability due to heat exposure.[12–15] Our previous
study reported a novel co-crystal from acid form of diclofenac
(DA), with L-proline (LP) as the co-former.
We termed the co-crystal a diclofenac-proline co-crystal
(DPC) and we screened the 3D structure and studied its co-
crystallization using the neat-grinding method.[16–17] To scale up
the preparation of the co-crystals in the laboratory, in addition
to neat and solvent dropped grinding, we attempted co-
melting/extrusion but it failed due to the instability of the
components at the high temperature required. Compared with
other methods, our findings indicated that the best method for
the preparation of DPC was the liquid-assisted grinding
technique. However, since this method is performed manually,
it is difficult to measure the energy involved as well as to
quantify, validate, and standardize the method.[18]
Currently, microwaving is widely employed in chemical
research and industry. In general, microwaving works by
exciting the rotational energy using the wavelength on a
meter–micrometer scale.[19–22] This technique has been tried for
various extraction, chemical production, and crystal engineer-
ing processes, and has been proven to be more sustainable
than conventional methods.[23–27] However, to date, microwav-
ing is not frequently used for co-crystallization, only a few
reports about it.[28–32]
The aim of this study was to develop a method for the
preparation of DPC using a domestic microwave (MW) with low
energy (399 W). This trial was based on previous conventional
methods that are solvent-drop grinding and neat
grinding.[4–7,16–7] The process was then further investigated to
better understand the dynamic co-crystal formation with the
MW. In previous research, we used diffractogram profile to
determine the kinetic of co-crystal production with neat
grinding method. Meanwhile, in present MW method develop-
ment kinetic study we used Fourier-transform infrared (FTIR)
spectra.
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In addition, we evaluated physical and chemical stability of
the DPC, along with other crucial factors such as the dissolution
and diffusion, which had previously not been studied. Finally,
the in-vivo anti-inflammatory activity of the DPC was examined
using Wistar rats after ethical and protocol approval. All results
demonstrated integrated and consistent data, confirming that
DPC improve the pharmaceutical aspects and in-vivo activity of
DA. Collectively, this research findings supported data that DPC
is a promising candidate for development in dosage form
formulations which is able to be generated using MW.
Results and Discussion
Characterization and kinetics study using Fourier-transform
infrared (FTIR)
Previous studies of co-crystal dynamics have been performed
using infrared instruments such as near infrared, Raman and
even rarely FTIR.[16–17,33] In this study, FTIR was used to observe
changes in the spectra at wavelength regions of � 3170–3175
and 3268–3271 cm@1, which presented the intra-molecular
hydrogen bond of -NH***O=C in DPC, as well as the broad
spectra at � 1950–2000 cm@1.[16–17] The result of FTIR analysis
are depicted in Figure 2 as the first characterization of the co-
crystal formation.
The time when the maximum AUC reached the steady state
can be considered as the optimum time for processing.
Figure 2a revealed that the DPC produced by MW-assisted-
ethanol. was reached optimally after 5–12 minutes. After 12
minutes, the AUC decreased, indicated the breaking of hydro-
gen bonding. Near the melting point, the specific peaks of DPC
were lost, that are the area of 3170–3175 cm@1 and 1950–
2000 cm@1.
Ethanol system produced co-crystal immediately after the
addition of solvent (Figure 2a), While distinctive DPC peaks
from methanol system can only be clearly observed after 1
minute of MW treatment (Fig 2b). Furthermore, physically,
ethanol and methanol-assisted system melted at different
times. Melting occurred after 20 minutes for ethanol and after
25 minutes for methanol. This result revealed that MW-assisted
ethanol produced DPC more efficiently than MW-assisted
methanol. However, Figure 2a-b indicated that ethanol and
methanol systems have similar optimum time for co-crystal-
lization. Figure 2b shows that optimum time for MW-assisted
ethanol as well as MW-assisted methanol are 5–12 minutes,
indicated by the occurrence of specific DPC peaks after this
time. After the optimum time, FTIR spectra is shown to
decrease gradually until the melting point. Meanwhile, MW-
assisted-water system and neat mixture had optimum times of
15–25 and 30–40 minutes and then melted at 40 and 45
minutes, respectively (Figure 2c and 2d). After melting, the
compound produced from these methods was unstable, as
shown by the irregular and yellow-brownish color-fused liquid
in Figure 3. The conditions of the melted mixtures are shown in
Figure 3a-d below.
Figure 1. Chemical structure of diclofenac acid (left) and L-proline (right)
Figure 2. FTIR spectra compilation of DPC from MW treatment: (a) assisted by ethanol, (b) assisted by methanol, (c) assisted by water and (d) neat mixture.
Note: red arrows marked the specific peaks of DPC formation.
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Due to its high specificity and clarity, the spectra at �
1950–2000 cm@1 was selected to measure the kinetics of
crystallization. To increase selectivity, the FTIR spectra were first
derived and the changes during the MW method are presented
in Figure 4. The area under the curve (AUC) of the absorbance
was found to be correlated with the amount of DPC. Figure 5
shows the order reaction generated from the increasing curve.
We focused on the specific spectra at 1970–200 cm@1 to be
monitored as shown in Figure 4. The changes in the DPC
vibrational energy due to intermolecular hydrogen bonds
formation are shown to increase until the optimum, then
decrease.
The kinetics were then analyzed, which resulted in the
profile depicted in Figure 5. Our results then revealed the
polynomial profile, which resulted in the quadratic equations,
indicating that co-crystal formation follows a second order
reaction. This data differs from previous reports indicating that
the neat-grinding co-crystallization method proceeds with a
first order profile.[16–17] It is likely that the differences are due to
the different energy types used in the different methods.
The heating characteristics of a particular material (e.g., a
solvent) under MW irradiation conditions are dependent on the
ability of a specific substance to convert electromagnetic
energy into kinetic energy. The MW method require solvent
with a high value for this parameter in order to support the
rapid nature of this process. Commonly organic solvents are
classified according to their heating efficiency in the MW field,
with the heating efficiency of ethanol 0.941, followed by
methanol at 0.659, and water at 0.123.[34–35] In this case, the
hydroxyl group of the ethanol bridges the formation of
hydrogen bonds, which are supported by the increasing
rotational energy from the molecules of both components and
is faster than methanol and water. A longer alkyl chain than
methanol causes the -OH to become more active.[36] Without
organic solvent support, DPC can be prepared. However, longer
time is required to activate the kinetic energy between the two
compounds. The longer process can be compared with analog
processes such as neat grinding; however, this method is more
time intensive than solvent dropped grinding.[17]
This phenomenon can also be explained with other
reasons. In addition to the highest rotation energy of methanol
and ethanol compared with the other materials used, the
volatility/penetration of these solvents is appropriate to reach
the deepest layer of the solid molecules.[29] Furthermore, the
dielectric constant is congenial to the DPC binary system.[34–35]
Finally, other variables are affected by different factors,
including the powder‘s charge, moisture content, and fre-
quency of rotational energy.
Differential scanning calorimetry (DSC) and powder X-ray
diffractometry (PXRD) confirmation
The thermograms collected from DSC and diffractogram from
PXRD measurement were shown in Figure 6 and 7. DPC
products from the optimum time which were 5–12 minutes of
MW using methanol and ethanol, 15–40 minutes for water, and
30–45 minutes for the neat system have a distinctive melting
point at around 156.7–158.7 °C. The endothermic curves of DPC
from methanol, ethanol, and water system were symmetrical
and close to the single crystal’s reported before, compared to
the physical mixture which positioned in the top of Figure 6.[17]
However, the thermogram of the neat mixture was not
symmetrical. It is indicated that the neat system did not able to
yield the cocrystal purely even until 30–45 minutes.
The thermal profile then was confirmed with PXRD data in
Figure 7. In this figure, the peak patterns were compared with
the previous reports of the standard. All diffractograms show
the specific peaks on 2θ=4.29°; 9.73°; 11.54°; 13.18°; 14.31°;
19.42°; 20.48°; and 25.46°; these are equal to the reported DPC
as the reference, with the specific peak at 2θ=9.84°. The red
star in Figure 7 represents the 1–0-0 plane.[17]
However, confirming DSC result, diffractogram of the neat
system still showed some small peaks remained from the
starting material’s, signed by the yellow stars. Neat system also
can produce DPC, however it needs the longer time (30-45
minutes), which caused the breaking of intermolecular bonding
before the proper result is yielded. All data lead to conclude
that the best systems for co-crystallization are MW-assisted-
ethanol and MW-assisted-methanol, followed by water system
and the neat system.
Figure 3. Melted DPC after (a) 20 minutes for MW-assisted-ethanol system,
(b) 25 minutes for MW-assisted-methanol system, (c) 40 minutes for MW-
assisted-water system, and (d) 45 minutes for neat mixture.
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Chemical stability testing using thin layer chromatography
(TLC), ultraviolet (UV) spectroscopy, and reverse-phase high
performance liquid chromatography (HPLC)
The chemical stability was analyzed by TLC, UV spectrometry,
and HPLC. Firstly, TLC result (Supplementary Material, Figure 2)
revealed that no other spot except DA exists until the melting
point of co-crystals, indicating that the MW did not destroy the
active compound. All samples show only the similar diclofenac
spot, with no changes shown by L-proline spot. These results
confirm that no chemical changes occurred during the MW
time of each system. Next, as shown in Figure 8, the UV spectra
at 276 nm show no change of the drug in DPC from the MW
method.
Lastly, HPLC analysis was conducted to further confirm
previous analysis result. The chormatograms are depicted in
Figure 9(a) and (b). As shown in Figure 9(a), DPC sampled at
optimum MW time period for every production method
developed in this research were compared to the physical
mixture. All DPC sample generated peaks with similar AUC and
retention time to physical mixture after detection at 254 nm.
However, upon exceeding optimum time, DPC powder melted,
followed by the degradation of co-crystal. After melted, new
peaks occurred and the chromatogram was different to that of
physical mixture. This observation suggests the possibility of
degradation product.
Afterward, all systems were checked by focusing on the
time of retention of DA, that is 5.24 minutes as shown in Fig
9(b). Here is shown that all chromatograms from ethanol,
methanol, water, and neat system, have the similar retention
time and AUC. This confirmed the stability of systems until
optimum time period of MW process. By combining the kinetic
and stability data, the duration of MW treatment for each
solvent system in DPC production can be standardized for
future application.
All physical and chemical data support the conclusion that
the homogeneous DPC can be obtained quickly using MW
treatment due to the efficiency of the energy transferred by
the equipment. This is in line with the strategic future goals of
environmental conservation, which involves less chemicals and
reagent, and includes reduced energy consumption, waste, and
pollutants.[37–38] The next experiment results then describe the
impact of DPC formation on the drug performance by a series
of dissolution, diffusion, and by anti-inflammatory test.
Figure 4. Absorbance intensity changes in FTIR spectra at 1970–2010 cm@1 in: (a) MW-assisted-ethanol system, (b) MW-assisted-methanol system, (c) MW-
assisted-water system, and (d) neat mixture.
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Dissolution testing
Ethanol and methanol systems were the two most efficient MW
co-crystal production method, which generated DPC with
almost identical characteristics and stability profile. Therefore,
only one representative (MW-assisted-ethanol system) was
chosen for in-vitro dissolution and diffusion testing. Along with
the solubility improvement, dissolution testing in stomach and
intestine medium[39] showed an increasing dissolution rate of
DPC (collected from the ethanol system) as depicted in
Figure 10. Indeed, DPC released the parent drug faster than did
pure DA, as determined by the zwitterionic capacity, which
increased the rate and solubility of both media types. At
pH 1.2, DA was released at a maximum of 20% from the DPC
after 30 minutes, compared with DA was released at a
maximum of 12% after 60 minutes and from physical mixture
after 45 minutes as much as 15%. This result showed that the
dissolution of DA in pH 1.2 was poor, due to the acidity of DA
(pKa=4.8), the total drug released amount was very limited at
this pH. As well as the previous data, Figure 10 shows that the
DA was completely released at pH 6.8 after 30 minutes from
the DPC, 45 minutes from DA, and 60 minutes from physical
mixture. However, in pH 6.8, almost all drugs were released.
These data confirm that the DPC had an improved dissolution
profile from that of DA significantly in the intestinal pH. LP in
physical mixture also pushed the dissolution rate due to its
properties as a deep eutectic solvent in the solution, which has
been established in many reports.[38–41] However, DPC remain
superior by increasing the DA dissolution rate compared to DA
alone and physical mixture.
Diffusion testing
Diffusion testing was conducted with two similar media
samples used in dissolution test and the results are shown in
Figure 11. These experiments also revealed a similar phenom-
enon in that DPC was predominant, with an increasing rate and
quantity of DA diffusion up to � 4 folds. The DPC diffused
maximally after 2 hours, followed by PM and the pure DA.
Furthermore, diffusion testing results revealed that the highest
penetration occurred from the DPC system in pH 6.8.
Anti-inflammatory activity testing
Inhibition of an inflammatory response is presented as a
percentage. Our experimental results from pure DA, DPC from
the MW-ethanol and methanol system (chosen as the two most
efficient co-crystal production method), and carrageenan as a
positive control are shown in Table 1 and Figure 12. Both DPC
obtained from MW-water system and neat mixture were
omitted from in-vivo study, assuming no potential inflamma-
tion inducer (e.g. organic solvent) used during production. Our
results had a p value < 0.05, with the data showing a normal
distribution. Finally, in-vivo test results are shown in Figure 12.
On the histogram, the increase in inflammation in the
maximum control group occurred in the third hour. The
inflammation was caused by the release of prostaglandin in the
third phase so that the resulting inflammation was at a
maximum.[42] Carrageenan can induce inflammation in three
phases, with the first phase being histamine and 5-HT release.
Figure 5. The kinetic equation of: (a) MW-assisted-ethanol system, (b) MW-assisted-methanol system, (c) MW-assisted-water system, and (d) neat mixture.
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The second phase is mediated by kinin, while the third phase is
mediated by prostaglandin.[43]
The administration of DPC can inhibit inflammation from
the first hour after carrageenan administration. Inhibition of
inflammation by the DA group, which were significantly distinct
from the positive control group was achieved at 1 to 3 hours.
Meanwhile, the DPC group showed significantly greater
inhibition compared with the other groups, from the first to
the sixth hour. However, the work-onset factor of the DPC was
not signed to be changed. Judging from the data, DPC revealed
� 1.5 times stronger than DA. This increasing effect is expected
to be supported by the increase in solubility, dissolution, and
diffusion as explained previously. As the final impact, the rate
of absorption should be going up. Therefore, it can be
concluded that the solubility of DA is the determinate step for
the dissolution, diffusion, and absorption rate of the DPC. As
shown in Figure 12, anti-inflammatory activity of DPC prepared
with the assistance of either methanol or ethanol are similar
statistically.
Conclusions
Present experiment has proven that microwave can produce
homogenous diclofenac-proline co-crystal either with the
assistance of methanol, ethanol, water, or a neat system and
follows a second order kinetics. The ethanol dropped MW was
the fastest method, followed by methanol and water. The
Figure 6. DSC thermogram of: (a) physical mixture, (b) DPC from MW-
assisted-ethanol system, (c) DPC from MW-assisted-methanol system, (d) DPC
from MW-assisted-water system, and (e) DPC from neat mixture after each
optimum time of heating.
Figure 7. X-ray powder diffractogram of: (a) physical mixture, (b) DPC from
MW-assisted-ethanol system, (c) DPC from MW-assisted-methanol system, (d)
DPC from MW-assisted-water system, (e) DPC from neat mixture and (f) DPC
calculated as the reference. All diffractograms of MW system reveal a
different pattern from PM and similar to the calculated standard.
Figure 8. UV absorbance spectra of DPC sampled before melting.
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longest process was the neat system without any liquid
dropped. The novel findings indicated that diclofenac-proline
co-crystal increase the dissolution and diffusion rate of the acid
form of diclofenac, and produced 1.5 times higher anti-
inflammatory activity, with a longer duration of effect. Thus,
with a simple and inexpensive process, this technique can be
developed as a green and cost-efficient method for scaling up
the production of diclofenac-proline co-crystal for further
research and drug development.
Supporting Information Summary
Solvent-assisted microwave method for diclofenac-L-proline co-
crystal preparation, characterization, performance evaluation
and stability study are described. From kinetic model evalua-
tion, ethanol was found to be the best solvent in assisting the
formation of intermolecular interaction between diclofenac
acid and L-proline which was reached after only 5 minutes of
microwaving. The resulting co-crystal will eventually revert to
its starting materials after the optimum microwaving period are
exceeded. No degradation products were observed after MW
treatment until optimum time period was reached.
Figure 9. (a) overlaid chromatograms of (1) melted MW-assisted-ethanol
system sampled at 20 minutes, (2) melted MW-methanol system sampled at
25 minutes, (3) melted MW-assisted-water system sampled at 40 minutes, (4)
MW neat mixture sampled at 45 minutes, (5) physical mixture, (6) MW-
assisted-ethanol system at optimum point, (7) MW-assisted-methanol system
at optimum point, (8) MW-assisted-water system at optimum point, (9) neat
mixture at optimum point and (b) overlaid chromatograms of: (1) physical
mixture as the reference; (2-5) MW-assisted-ethanol system after micro-
waving for 5, 10, 12 minutes, respectively; (6-8) are the chromatograms of
MW-assisted-methanol system after 5, 10, 12 minutes, respectively; (9-10)
MW-water-system after 15 and 25 minutes; (11-12) neat system after 30 and
40 minutes (b).
Figure 10. Dissolution profile of MW-assisted-ethanol system (DPC) com-
pared to diclofenac acid (DA) and physical mixture (PM) in pH 1.2 and 6.8
media.
Figure 11. Diffusion profile of MW-assisted-ethanol system (DPC) compared
to diclofenac acid (DA) and physical mixture (PM) in pH 1.2 and 6.8 media.
Figure 12. The inflammation volume percentage of carrageenan, diclofenac
acid (DA), MW-assisted-ethanol system (DPC MW-AE) and MW-assisted-
methanol system (DPC MW-AM) groups in 6 h observation.
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